Log in to save to my catalogue

Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema

Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_02318184v1

Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

The clinical consequences of defects in C1 inhibitor function can be serious. A series of advances have improved the outlook for patients with hereditary angioedema. The latest development is an effective oral kallikrein inhibitor that reduces the attack rate by nearly 75%.

Alternative Titles

Full title

Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_hal_primary_oai_HAL_hal_02318184v1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_02318184v1

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa1716995

How to access this item